Organization Overview
Alternative names
fludeoxyglucose f-18 (2004)
acetaminophen (tylenol) (4 trials)
acetylsalicylic acid (aspirin) (8 trials)
adenosine (Adenocard) (1 trial)
armodafinil (nuvigil) (1 trial)
atazanavir (reyataz) (1 trial)
beclomethasone (vanceril) (3 trials)
bictegravir (Biktarvy) (2 trials)
bortezomib (velcade) (23 trials)
bupivacaine (Exparel) (1 trial)
bupropion (wellbutrin) (2 trials)
clopidogrel (plavix) (2 trials)
corticotropin (acthar) (3 trials)
dapagliflozin (farxiga) (2 trials)
daptomycin (cubicin) (1 trial)
desogestrel (Mercilon) (1 trial)
duloxetine (Cymbalta) (1 trial)
efavirenz (sustiva) (3 trials)
emtricitabine (emtriva) (5 trials)
enoxaparin (lovenox) (2 trials)
escitalopram (lexapro) (11 trials)
esomeprazole (nexium) (1 trial)
estradiol (progynon depot) (2 trials)
ethinyl estradiol (Estinyl) (2 trials)
fesoterodine (toviaz) (1 trial)
fondaparinux sodium (arixtra) (1 trial)
insulin degludec (tresiba) (1 trial)
insulin glargine (toujeo) (1 trial)
insulin human (humulin) (2 trials)
ketorolac (acuvail) (2 trials)
lactulose (cephulac) (2 trials)
ledipasvir (Harvoni) (1 trial)
leuprolide (lupron) (10 trials)
levobupivacaine (chirocaine) (5 trials)
metformin (glucophage) (3 trials)
metoclopramide (reglan) (1 trial)
metoprolol (lopressor) (2 trials)
micafungin (mycamine) (1 trial)
mirtazapine (remeron) (1 trial)
mycophenolate (myfortic) (8 trials)
naltrexone (revia) (22 trials)
nebivolol (bystolic) (1 trial)
nystatin (mycostatin) (1 trial)
olanzapine (zyprexa) (3 trials)
omeprazole (prilosec) (1 trial)
ondansetron (zofran) (2 trials)
patiromer (veltassa) (1 trial)
perampanel (fycompa) (1 trial)
pibrentasvir (Mavyret) (1 trial)
polyethylene glycol (3 trials)
posaconazole (noxafil) (1 trial)
potassium citrate (urocit-k) (1 trial)
propofol (diprivan) (6 trials)
propranolol (inderal) (1 trial)
quetiapine (seroquel) (2 trials)
recombinant human choriogonadotropin alfa (Ovidrel) (2 trials)
Rho(D) Immune Globulin Intravenous (Human) (WinRho) (1 trial)
ribavirin (virazole) (10 trials)
rifaximin (xifaxan) (3 trials)
rimabotulinumtoxinB (Myobloc) (4 trials)
risedronate (actonel) (2 trials)
risperidone (risperdal) (2 trials)
sargramostim (leukine) (91 trials)
sertraline (zoloft) (3 trials)
sildenafil (viagra) (7 trials)
sofosbuvir (sovaldi) (2 trials)
somatropin (protropin) (3 trials)
tacrolimus (prograf) (6 trials)
tenofovir alafenamide (genvoya) (3 trials)
treprostinil (remodulin) (1 trial)
triamcinolone (kenalog) (2 trials)
unfractionated heparin (1 trial)
valproic acid (depakene) (2 trials)
velpatasvir (Epclusa) (1 trial)
abiraterone (zytiga) (5 trials)
acetylcysteine (mucomyst) (7 trials)
allogeneic hematopoietic stem cells (Hemacord) (11 trials)
alteplase (Activase) (2 trials)
amiodarone (cordarone) (2 trials)
amphotericin b (fungizone) (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (13 trials)
atorvastatin (lipitor) (2 trials)
autologous bone marrow (10 trials)
autologous mononuclear stem cell (5 trials)
bacampicillin (spectrobid) (1 trial)
bacille calmette-guerin (4 trials)
bevacizumab (avastin) (41 trials)
bicalutamide (casodex) (8 trials)
bleomycin (blenoxane) (6 trials)
calcitriol (rocaltrol) (4 trials)
carbenicillin (pyopen) (1 trial)
carboplatin (paraplatin) (48 trials)
carmustine (bicnu) (14 trials)
caspofungin (cancidas) (1 trial)
cetuximab (erbitux) (17 trials)
ciprofloxacin (cipro) (1 trial)
cisplatin (platinol) (93 trials)
clarithromycin (biaxin) (9 trials)
clavulanate (Augmentin) (1 trial)
conjugated equine estrogens (1 trial)
COVID-19 convalescent plasma (2 trials)
cytarabine (cytosar-u) (36 trials)
dactinomycin (cosmegen) (4 trials)
daunorubicin (cerubidine) (9 trials)
degarelix acetate (firmagon) (5 trials)
dexmedetomidine (precedex) (3 trials)
docetaxel (taxotere) (38 trials)
doxorubicin (Doxil) (58 trials)
doxycycline (vibramycin) (3 trials)
enzalutamide (xtandi) (6 trials)
etoposide (vepesid) (54 trials)
filgrastim (neupogen) (14 trials)
floxuridine (fudr) (16 trials)
fludeoxyglucose f-18 (19 trials)
fluorouracil (efudex) (42 trials)
foscarnet (foscavir) (2 trials)
gabapentin (neurontin) (1 trial)
ganciclovir (cytovene) (2 trials)
gemcitabine (gemzar) (50 trials)
glycopyrronium (robinul) (1 trial)
goserelin (zoladex) (5 trials)
hepatitis b vaccine (recombinant) (recombivax) (1 trial)
human papillomavirus 9-valent vaccine, recombinant (Gardasil 9) (2 trials)
human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (2 trials)
immune globulin (human) (3 trials)
indocyanine green (ic-green) (1 trial)
interferon alpha-2b (Intron-A) (16 trials)
in vitro-treated bone marrow (4 trials)
lenalidomide (revlimid) (29 trials)
mebendazole (vermox) (1 trial)
mercaptopurine (purinethol) (2 trials)
methylprednisolone (medrol) (5 trials)
mezlocillin (mezlin) (1 trial)
mitomycin (mutamycin) (2 trials)
mitoxantrone (novantrone) (5 trials)
neostigmine (bloxiverz) (1 trial)
olaparib (lynparza) (5 trials)
onabotulinumtoxinA (Botox) (2 trials)
oxaliplatin (eloxatin) (26 trials)
paclitaxel (taxol) (69 trials)
palivizumab (Synagis) (1 trial)
pasireotide (signifor) (3 trials)
pegaspargase (oncaspar) (2 trials)
pemetrexed (alimta) (9 trials)
polyvalent antigen-klh conjugate vaccine (1 trial)
porfimer (photofrin) (2 trials)
prednisone (meticorten) (30 trials)
procaine benzylpenicillin (novocaine) (3 trials)
progesterone (progestasert) (1 trial)
rituximab (rituxan) (48 trials)
roflumilast (daliresp) (1 trial)
sorafenib (nexavar) (16 trials)
sulfamethoxazole (gantanol) (1 trial)
tamoxifen (nolvadex) (3 trials)
temozolomide (temodar) (27 trials)
tetracaine (pontocaine) (1 trial)
tivozanib (Fotivda) (4 trials)
vancomycin (Vancocin) (3 trials)
vinblastine (velban) (10 trials)
68ga−psma−hbed−cc (3 trials)
7-hydroxystaurosporine (2 trials)
90y-epratuzumab tetraxetan (1 trial)
abaloparatide (tymlos) (1 trial)
abemaciclib (verzenio) (2 trials)
acalabrutinib (calquence) (2 trials)
adenoviral vector expressing hsv-tk (1 trial)
afatinib (gilotrif) (3 trials)
aflibercept (zaltrap) (5 trials)
aldesleukin (proleukin) (9 trials)
alemtuzumab (campath) (4 trials)
allogeneic epstein-barr virus specific cytotoxic t-lymphocytes (2 trials)
allogeneic stem cells (3 trials)
amlodipine (norvasc) (2 trials)
amonafide dihydrochloride (1 trial)
anastrozole (arimidex) (2 trials)
apalutamide (erleada) (3 trials)
arsenic trioxide (trisenox) (13 trials)
arzoxifene hydrochloride (2 trials)
asparaginase (elspar) (3 trials)
atezolizumab (tecentriq) (4 trials)
autologous ebv specific cytotoxic t lymphocytes (1 trial)
autologous genetically modified t cells, ny-eso-1c259 t (1 trial)
autologous hematopoietic cell (4 trials)
autologous lymphocytes (2 trials)
autologous umbilical cord blood (4 trials)
azacitidine (vidaza) (7 trials)
bcr-abl peptide vaccine (1 trial)
bendamustine (treanda) (5 trials)
bexarotene (targretin) (2 trials)
binimetinib (mektovi) (3 trials)
brentuximab vedotin (adcetris) (5 trials)
busulfan (myleran) (11 trials)
cabazitaxel (jevtana kit) (2 trials)
cabozantinib (cometriq) (3 trials)
capecitabine (xeloda) (15 trials)
carfilzomib (kyprolis) (4 trials)
clofarabine (clolar) (4 trials)
clonidine (catapres) (3 trials)
cmv-specific t-cells (3 trials)
cobimetinib (cotellic) (2 trials)
cyanocobalamin (berocca) (1 trial)
cyclosporine (sandimmune) (6 trials)
dabrafenib (tafinlar) (3 trials)
dacarbazine (dtic-dome) (6 trials)
daratumumab (darzalex) (3 trials)
darbepoetin alfa (aranesp) (1 trial)
dasatinib (sprycel) (7 trials)
decitabine (dacogen) (7 trials)
deferasirox (exjade) (1 trial)
deferiprone (ferriprox) (2 trials)
deferoxamine (desferal) (4 trials)
dexrazoxane (zinecard) (2 trials)
diphtheria-tetanus-acellular pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine (1 trial)
disaccharide tripeptide glycerol dipalmitoyl (1 trial)
dolutegravir (tivicay) (1 trial)
durvalumab (imfinzi) (14 trials)
eltrombopag (promacta) (4 trials)
encorafenib (braftovi) (1 trial)
epirubicin (ellence) (4 trials)
erlotinib (tarceva) (15 trials)
estramustine (emcyt) (3 trials)
etaracizumab (abegrin) (1 trial)
everolimus (zortress) (20 trials)
fludarabine (fludara) (23 trials)
ga-68-dota-toc (Ga-68-dota-toc) (2 trials)
gallium-68-dotatate (netspot) (1 trial)
gemtuzumab ozogamicin (mylotarg) (2 trials)
gene-modified tumor cell vaccine therapy (1 trial)
gp-100 peptide vaccine (1 trial)
haplo-identical cord blood (1 trial)
hemopoietic stem cell (3 trials)
hla-matched related donor bone marrow (1 trial)
human dehydrated amnion chorion allograft (1 trial)
human fecal microbiota (4 trials)
ibritumomab tiuxetan (zevalin) (2 trials)
ibrutinib (imbruvica) (7 trials)
icosapent ethyl (vascepa) (1 trial)
idarubicin (idamycin) (4 trials)
inactivated influenza vaccine (1 trial)
incomplete freund's adjuvant (3 trials)
indigotindisulfonate sodium (1 trial)
interferon gamma-1b (actimmune) (1 trial)
interleukin-22 igg2-fc (1 trial)
in vitro-treated peripheral blood stem cell (1 trial)
iobenguane sulfate i-131 (1 trial)
ipilimumab (yervoy) (18 trials)
irinotecan (Camptosar) (40 trials)
isavuconazonium (cresemba) (1 trial)
isoniazid (nydrazid) (2 trials)
ixabepilone (ixempra) (9 trials)
ketoconazole (nizoral) (3 trials)
keyhole limpet hemocyanin (2 trials)
klh-linked gd2l and gd3l (1 trial)
labetalol (trandate) (1 trial)
lamivudine (epivir) (4 trials)
lenvatinib (lenvima) (1 trial)
lu177 monoclonal antibody j591 (2 trials)
lymphokine-activated killer cells (1 trial)
maitake mushroom extract (1 trial)
maraviroc (selzentry) (2 trials)
mechlorethamine (mustargen) (1 trial)
medroxyprogesterone (provera) (1 trial)
melphalan (alkeran) (33 trials)
methadone (methadose) (2 trials)
methyldopa (aldomet) (1 trial)
methylphenidate (ritalin) (2 trials)
midostaurin (rydapt) (1 trial)
minocycline (minocin) (3 trials)
mogamulizumab (poteligeo) (1 trial)
motexafin gadolinium (1 trial)
nifedipine (procardia) (1 trial)
nitazoxanide (alinia) (3 trials)
nivolumab (opdivo) (16 trials)
ny-eso-1 and melan-a/mart-1 peptides (1 trial)
ny-eso-1(c259)t cells (1 trial)
ofatumumab (arzerra) (1 trial)
osimertinib (tagrisso) (1 trial)
oxycodone (oxycontin) (1 trial)
palbociclib (ibrance) (8 trials)
palifermin (kepivance) (3 trials)
palonosetron (aloxi) (1 trial)
panitumumab (vectibix) (4 trials)
pazopanib (votrient) (3 trials)
pegylated arginine deiminase (5 trials)
pembrolizumab (keytruda) (12 trials)
pentostatin (nipent) (3 trials)
pertuzumab (perjeta) (5 trials)
pexidartinib (Turallo) (2 trials)
pioglitazone (actos) (2 trials)
plerixafor (mozobil) (4 trials)
pneumococcal 13-valent conjugate vaccine (prevnar 13) (1 trial)
polatuzumab vedotin (Polivy) (1 trial)
procarbazine (matulane) (7 trials)
pyrimethamine (daraprim) (1 trial)
radium-223 (xofigo) (2 trials)
ramucirumab (cyramza) (2 trials)
regorafenib (stivarga) (2 trials)
ribociclib (kisqali) (1 trial)
rifapentine (priftin) (2 trials)
romidepsin (istodax) (6 trials)
romiplostim (nplate) (2 trials)
ruxolitinib (jakafi) (4 trials)
sitagliptin (januvia) (3 trials)
sodium phenylbutyrate (buphenyl) (1 trial)
talimogene laherparepvec (Imlygic) (1 trial)
t-cell depleted peripheral blood stem cells (1 trial)
telaprevir (incivek) (1 trial)
temsirolimus (torisel) (8 trials)
testosterone (delatestryl) (3 trials)
thalidomide (Thalomid) (16 trials)
tioguanine (Lanvis) (2 trials)
tocilizumab (actemra) (2 trials)
topotecan (hycamtin) (11 trials)
trabectedin (yondelis) (3 trials)
trametinib (mekinist) (5 trials)
trastuzumab (herceptin) (18 trials)
trastuzumab emtansine (kadcyla) (1 trial)
tretinoin (Retin-A) (6 trials)
trimetrexate (neutrexin) (3 trials)
triptorelin (Trelstar) (1 trial)
trivalent ganglioside vaccine (1 trial)
tumor-pulsed dendritic cells (2 trials)
valaciclovir (Valtrex) (1 trial)
vandetanib (caprelsa) (1 trial)
vemurafenib (zelboraf) (6 trials)
vinorelbine (navelbine) (7 trials)
vismodegib (erivedge) (1 trial)
vorinostat (zolinza) (9 trials)
124i-iodo-azomycin galacto-pyranoside (1 trial)
18f 4-l-fluoroglutamine (1 trial)
4h11-28z/fil-12/efgrt+ genetically-modified t cells (1 trial)
70-kd heat-shock protein (1 trial)
allogeneic natural killer cells (1 trial)
aluminum hydroxide (Gaviscon) (1 trial)
autologous cd34+ cells transduced with tns9.3.55 (1 trial)
capromab pendetide (Prostascint) (1 trial)
carboxyamidotriazole orotate (1 trial)
certolizumab pegol (cimzia) (1 trial)